ALACHUA, Fla. & SAN DIEGO--(BUSINESS WIRE)--Today Banyan Biomarkers, Inc. announced that the company has licensed its intellectual property related to traumatic brain injury (TBI) biomarkers to Abbott for assessment and verification. The terms of the agreement were not disclosed.
“Prior research has shown that protein markers are released in the bloodstream following a brain injury,” said Jackson Streeter M.D., CEO, Banyan Biomarkers. “Assessing these biomarkers is an important step forward in providing physicians with an objective test to evaluate patients who may have suffered a concussion.”
Hey, check out all the research scientist jobs. Post your resume today!
